• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail

Public Calendar: June 11-15, 2012

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

June 11-15, 2012
FDA Official and TitleDateLocationOther FDA ParticipantsNon-FDA ParticipantsSubject
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs6/11/12Silver Spring, MDVicki Seyfert-MargolisSeveral representatives from the State of Maryland, Montgomery County, Maryland, Global LifeSci Development Corporation and the IV2 LeaguePotential Public-Private Partnership Collaborations among FDA, Academia, Industry, and Healthcare Policy Stakeholders within LifeSci Village
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs6/12/12Silver Spring, MDSeveral FDA officials and staffShri Ghulam Nabi Azad (Minister of Health and Family Welfare for the Republic of India)Meet and Greet
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs6/12/12Silver Spring, MDDeb Autor, Murray Lumpkin, Mary Lou Valdez,Concepcion Cruz, Cathy Beck, Raphael Brykman, Lucinda Bushe, Cynthia Kleppinger, Mark Paxton, Carmelo Rosa, Carl Sciacchitano, Leigh Verbois, Vince Vilker, Shena Arellano, Cheryl DunhamDr. Elena Telnova (Roszdravnadzor)Opportunities for Ongoing and Future Bilateral Collaborations to Expand Regulatory Outreach
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs6/14/12Silver Spring, MDJohn Taylor, Lisa Barclay, Lisa Dwyer, Stephen Spielberg, Jeanne Ireland, Virginia Cox, Jeff Shuren, Karen Midthun, Janet Woodcock, Dara Corrigan, Vicki Seyfert-Margolis, Doug Throckmorton, Jennifer Devine, Lisa Rovin, Malcolm Bertoni, Cheryl DunhamShelly Hearne, Allan Coukell, Kathleen Stratton (Pew Health Group)Overarching PEW initiative called Innovate FDA to Help FDA Utilize Best Science and Regulatory Processes 
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs6/16/12Stanford, CAN/AN/ACommencement Address at Stanford University School of Medicine 
John M. Taylor, III, J.D., Counselor to the Commissioner6/12/12Silver Spring, MDN/AMitch Zeller (Pinney Associates)Tobacco
Deborah M. Autor, Esq., Deputy Commissioner for Global Regulatory Operations and Policy6/11/12Silver Spring, MDJennifer Devine, Carolyn Becker, Leigh VerboisMarjorie Clifton, Libby Baney (Center for Safe Internet Pharmacies)Meet and Greet
Dara A. Corrigan, Associate Commissioner for Regulatory Affairs6/11/12-6/15/12 N/AN/AN/ANo Significant Meetings
Virginia Cox, Associate Commissioner for External Affairs6/11/12-6/15/12N/AN/AN/ANo Significant Meetings
Lawrence Deyton, M.S.P.H., M.D., Director, Center for Tobacco Products9/12/12Washington, DCAmy Hertz, Jennifer CarusoSeveral representatives from the National Association of Tobacco OutletsStakeholder Outreach
Elizabeth H. Dickinson, Esq., Chief Counsel6/11/12-6/15/12N/AN/AN/ANo Significant Meetings
David Dorsey, J.D., Acting Associate Commissioner for Policy and Planning6/11/12-6/15/12N/AN/AN/ANo Significant Meetings
Bernadette Dunham, D.V.M., Ph.D., Director, Center for Veterinary Medicine6/11/12Washington, DCN/ANational Renderers AssocationCenter for Veterinary Medicine Update
Jesse Goodman, M.D., M.P.H., Chief Scientist6/12/12-6/14/12Prague, Czech RepublicN/AVarious participants from private industry, Government, academia, and international expertsHealth and Environmental Science Institute on Emerging Issues
Michael M. Landa, Director, Center for Food Safety and Applied Nutrition6/12/12Chicago, ILN/AAmerican Bar Association (ABA)Update on Food Safety Modernization Act (FSMA)
Walter Harris, Chief Operating Officer6/11/12-6/15/12N/AN/AN/ANo Significant Meetings
Karen Midthun, M.D., Director, Center for Biologics Evaluation and Research6/11/12-6/15/12N/AN/AN/ANo Significant Meetings 
Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health6/11/12-6/15/12N/AN/AN/ANo Significant Meetings  
William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research6/14/12-6/15/12Salzburg, AustriaN/AN/APlenary speech at the British Journal of Anaesthesia Special Workshop on Anesthesia, Neurotoxicity and Neuroplasticity
Stephen Spielberg, M.D., Ph.D., Deputy Commissioner for Medical Products and Tobacco6/14/12Silver Spring, MDN/ARichard Barker (Athenaeum Group)Personalized Medicine
Stephen Spielberg, M.D., Ph.D., Deputy Commissioner for Medical Products and Tobacco6/14/12Silver Spring, MDJeffrey Shuren, Elizabeth Mansfield, Tania Simoncelli, Michael PacanowskiMinnie Baylor-Henry (Johnson & Johnson); Jennifer Paine, Ann Quinn (Ortho Clinical Diagnostic); Jay Siegel, Deb Rasmussen (Janssen)Companion Diagnostics
Michael R. Taylor, J.D., Deputy Commissioner for Foods, Office of Foods6/11/12-6/15/12N/AN/AN/ANo Significant Meetings
Mary Lou Valdez, Associate Commissioner for International Programs6/13/12Silver Spring, MDSeveral FDA staffSeveral representatives from the World Health Organization (WHO)WHO Food Safety Initiatives
Mary Lou Valdez, Associate Commissioner for International Programs6/13/12Silver Spring, MDSeveral FDA staffSir Liam Donaldson and Dr. Edward Kelley (World Health Organization) Global Challenge on Medication Safety
Jill Hartzler Warner, J.D., Acting Associate Commissioner for Special Medical Programs6/11/12-6/15/12N/AN/AN/ANo Significant Meetings
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research6/13/12Silver Spring, MDHelen Winkle, Jeff Medwid, Bob Iser, Mansoor Khan, Lucinda BuhsePrabir Basu (NIPTE); Jim Michaels (Merck); Bruno Hancock (Pfizer); Paul Luner (Boeringer-Ingelheim); Ira Buckner (Duquesne University); Carl Wassgren (Purdue University); Steve Hoag (University of Maryland); Greg Amidon (University of Michigan); Calvin Sun (University of Minnesota); Jennifer Wang (BMS); Ann Christine Catlin (Purdue University)Understanding Excipient Performance-Key to Successful QbD Formulation Design